Back

TARGET AC sub-group analysis on diabetics and ACS patients.

29 August 2022 (13:05 - 13:15)
Organised by:
Congress Presentation Part of: 5-year outcomes of target all comers randomised trial & prospects of target series clinical trials Interventional Cardiology Open Access ESC Congress 2022

About the speaker

Photo
Professor Niels van Royen

Radboud University Nijmegen, Nijmegen (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Opening & target AC project introduction.
Professor A. Baumbach (London, GB)
Slides Video
Presentation thumbnail
5-year outcomes of target all comers randomised trial.
Doctor A. Lansky (New Haven, US)
Slides Video
Presentation thumbnail
Group discussion.
Doctor L. Janssens (Bonheiden, BE) Professor B. Xu (Beijing, CN) Doctor L. Holmvang (Copenhagen, DK) Doctor T. Johnson (Bristol, GB)
Video
Presentation thumbnail
Group discussion.
Doctor L. Holmvang (Copenhagen, DK) Professor B. Xu (Beijing, CN) Doctor T. Johnson (Bristol, GB) Doctor L. Janssens (Bonheiden, BE)
Video
Presentation thumbnail
Prospects of target series clinical trials.
Associate Professor G. Tarantini (Padova, IT)
Slides Video

Access the full session

Session thumbnail
5-year outcomes of target all comers randomised trial & prospects of target series clinical trials
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 13:05 CET
You may be interested in
thumbnail
Congress Presentation
Long-term PCI outcomes in chronic versus acute coronary syndromes: 5-year results of the TARGET All Comers trial
thumbnail
Congress Presentation
Redrawing the map: why we must cross boundaries in lipid management
thumbnail
Congress Session
Personalised management of patients with diabetes and coronary artery disease: unresolved issues

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources